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Cognitive-behavioral therapy for eating disorders in primary care settings:  1 
Does it work, and does a greater dose make it more effective? 2 
 3 
 4 
Abstract 5 
 6 
Objective: This study aimed to determine whether cognitive behavioral therapy (CBT) for 7 
eating disorders can be effective in a routine, primary care clinical setting, and to assess 8 
dose response.  9 
Methods: The participants were 47 patients who commenced treatment with a publicly-10 
funded primary care eating disorder service. They attended 7-33 sessions of individual CBT 11 
(mean = 17), using an evidence-based approach. Routine measures were collected pre- and 12 
post-therapy.  13 
Results: Three-quarters of the patients completed treatment. Using intention to treat 14 
analysis (multiple imputation), the patients showed substantial improvements in eating 15 
attitudes, bulimic behaviours and depression. However, there was no association between 16 
the level of improvement and the length of therapy past the 8th to 12th session 17 
Discussion: The level of effectiveness shown here is comparable to that previously 18 
demonstrated by more specialist services in secondary and tertiary care. The non-linear 19 
association between number of sessions and recovery highlights the importance of early 20 
change, across the eating disorders. 21 
 22 
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Cognitive-behavioral therapy for eating disorders in primary care settings:  1 
Does it work, and does a greater dose make it more effective? 2 
  Eating disorder services are configured differently both within and between countries, 3 
according to national and local patterns of provision. Many are specialist services at 4 
secondary or tertiary levels of care, taking referrals from more generalist primary care level 5 
services. However, such specialist services are not always present, and they do not always 6 
have the capacity to see the full range of patients with eating disorders (e.g., not accepting 7 
referrals for individuals with binge-eating disorder; not treating non-underweight cases). 8 
Where services have to select which patients they have the capacity to see, they are likely to 9 
focus on anorexia nervosa cases, given their higher risk levels. Such services also tend to 10 
see patients for extended periods of time. While existing evidence-based protocols 11 
recommend relatively long periods of treatment for eating disorders compared to anxiety and 12 
depressive disorders, it is clear that clinicians routinely extend therapy so that it is 13 
substantially longer than those recommendations (e.g., Cowdrey & Waller, 2015). 14 
Consequently, many clinicians and services have a relatively slow turnover of cases, making 15 
it even less likely that patients in the community will be able to access treatment. 16 
 As a result of this limited access to specialist services, some primary care eating 17 
disorders services have been established (Devlin, 2014) with the intention of providing 18 
treatment for normal-weight patients within non-specialist services. They do not have the 19 
range of professional backgrounds that are common in specialist eating disorders teams, but 20 
usually have training in appropriate therapies. For adult patients, this therapy base is 21 
commonly cognitive behavioral therapy (CBT), given its proven benefits in clinical trials 22 
(Fairburn et al., 2009) and in routine practice in specialist eating disorder services (Byrne, 23 
Fursland, Allen & Watson, 2011; Knott, Woodward, Hoefkens & Limbert, 2015; Turner et al., 24 
2015). However, no studies to date have explored the effectiveness of CBT for eating 25 
disorders when delivered in a primary care setting. This study addresses the effectiveness of 26 
CBT in such settings, in order to determine whether such services are able to provide 27 
outcomes that are comparable to those in secondary and tertiary care levels. 28 
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 In addition to providing access to services, it is also important to consider the 1 
duration of therapy in such settings. If therapy can be delivered over a shorter time frame, 2 
this would allow for more patients to be treated from within the same resources. While 3 
recommendations for length of treatment for CBT for eating disorders vary from 15-40 4 
sessions (depending on the version of CBT and the patient¶s BMI - Fairburn, 2008), there is 5 
provision within protocols for CBT to be extended if appropriate (Fairburn, 2008; Waller et 6 
al., 2007). However, effectiveness studies have also suggested that the therapy might be 7 
shortened in response to early changes, as well as allowing for extension (e.g., Turner et al., 8 
2015). While it might be assumed that adding more sessions would have a stronger clinical 9 
effect, there is some indication that therapy effects are not linear with time. There is usually a 10 
dose-response effect at first, which tails off to show limited or no gains thereafter. For 11 
example, Delgadillo et al. (2014) have demonstrated that the optimal length of therapy for 12 
mild to moderate anxiety and depression is approximately 4-6 sessions, and that additional 13 
sessions do not result in better outcomes. In the eating disorders, Bell et al. (2017) have 14 
shown a similar pattern in a specialist service ± within a group of patients receiving a mean 15 
of 16.2 sessions of one of a range of therapies, there was no link between treatment 16 
duration and outcomes, even among anorexia nervosa cases. Such a pattern stresses the 17 
importance of early gains, so that greater change levels are in place before the dose 18 
response effect has faded. However, the possibility of such a pattern is yet to be established 19 
in non-specialist eating disorders services of the type outlined above, to allow clinicians to 20 
plan for the optimum number of sessions to be offered. 21 
 Given the limited evidence base regarding eating disorder services in primary care 22 
settings, this study has two aims. First, it will determine whether CBT for eating disorders 23 
can be effective in a routine, primary care setting. Second, it will assess dose response - 24 
does the provision of more treatment sessions continue to facilitate further recovery gains? 25 
Method 26 
Ethics 27 
The local National Health Service (NHS) Research and Development Office 28 
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approved collection of these outcome data as a service evaluation. Thus, NHS Research 1 
Ethics Committee approval was not required. Service users provided consent for their data 2 
to be used for this purpose.    3 
Participants 4 
  The patients were aged 18 years or above at the point where they were referred to 5 
the service by their General Practitioner. All referred patients were triaged to ensure that 6 
they met the criteria for the service (body mass index  ; not requiring multiagency/ 7 
multidisciplinary care to address additional psychiatric or social needs; no alcohol or 8 
substance abuse; no psychotic diagnosis; medically stable and monitored by the responsible 9 
family physician). Each had a DSM-5 (American Psychiatric Association, 2013) diagnosis of 10 
anorexia nervosa, bulimia nervosa, atypical anorexia nervosa or atypical bulimia nervosa. 11 
Other OSFED cases and binge-eating disorder cases were not eligible for the service, due to 12 
local service commissioning arrangements. Unlike Knott et al. (2015), motivation to engage 13 
in therapy was not an eligibility criterion.  14 
All patients who attended for assessment and met the criteria agreed to participate in 15 
therapy (though some dropped out later ± see below). At the time of data collation, the case 16 
series consisted of 47 patients who started CBT for eating disorders with a UK primary care 17 
eating disorders service. Forty-four were female and three were male. Eleven had a 18 
diagnosis of anorexia nervosa and six had a diagnosis of atypical anorexia nervosa (BMI 19 
above 18 and below 20, with marked restriction of intake and current weight loss), while 29 20 
had a diagnosis of bulimia nervosa and one had a diagnosis of atypical bulimia nervosa 21 
(frequency of bulimic behaviour below the DSM-5 criteria). 22 
Treatment 23 
All patients were treated individually in primary care settings. They were seen by 24 
therapists who had been trained in the delivery of CBT via the UK Improving Access to 25 
Psychological Therapies (IAPT) programme, which is a scheme focusing on the delivery of 26 
evidence-based treatments (particularly CBT) for common psychological disorders (though 27 
not eating disorders). Each of the therapists was supervised weekly from within the team 28 
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(i.e., by other eating disorder clinicians with the same training background) rather than by 1 
external specialists. The therapists included one counsellor, two occupational therapists, a 2 
trainee clinical psychologist and one nurse.  3 
The CBT was based on individual case formulations, as described by Ghaderi 4 
(2006). Treatment included: conceptualisation of beliefs about food, eating, body image and 5 
emotion; sharing of information about regular eating, food and weight; in-session open 6 
weighing; support in identifying triggers to eating disorder behaviors through food records; 7 
and exposure/behavioral experimentation to address barriers to regular balanced, flexible 8 
eating. Where formulation identified maintenance caused by specific beliefs relating to the 9 
meaning of body image, those beliefs were targeted. Where behaviors such as body 10 
checking or avoidance were identified as maintaining body image importance, then 11 
behavioral experiments were planned as homework tasks. In-session mirror exposure was 12 
not used.  13 
Early sessions included completion of assessment and formulation, moving to the 14 
focus on behavioural change outlined above. When patients stated that they wanted to 15 
control their weight in a maladaptive way (e.g., restrict; remain underweight; avoid dietary 16 
normalisation), formulation and psychoeducation was used to Socratically explore the 17 
potential impact of making changes (e.g., reduced preoccupation, bingeing and purging; 18 
positive effect on relationships) in order to enhance motivation for change.  19 
Those starting treatment with a BMI of 17-18 were offered up to 30 weekly sessions 20 
in order to allow sufficient time for weight restoration. Other patients were usually offered up 21 
to 20 weekly sessions. Sessions were booked in 4-6 week blocks. 6 If the patient failed to 22 
develop motivation towards constructive change (e.g., they maintained efforts towards 23 
weight loss), therapists were advised to discontinue CBT after eight sessions. If recovery 24 
goals were achieved early (i.e., before the 20-30 sessions were concluded), therapists were 25 
advised to aim to complete sessions sooner, following completion of maintenance planning.    26 
Measures 27 
As indices of the dose of CBT, the number of sessions completed and the number of 28 
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weeks in therapy were recorded. Height and weight were measured at the outset of 1 
treatment, and weight was measured at each session thereafter. The duration of the eating 2 
disorder was recorded from clinical assessment. Each patient completed the following two 3 
well-validated measures at the beginning and end of therapy.   4 
 Eating Disorders Examination-Questionnaire (EDE-Q, version 6; Fairburn & 5 
Beglin, 2008). The EDE-Q is a 33-item self-report questionnaire, which measures disordered 6 
eating attitudes and behaviors over a 28-day period. The EDE-Q Global score is a summary 7 
of the four attitudinal subscales (Eating Concern, Shape Concern, Weight Concern, and 8 
Restraint). The Global score was used in this case because it has better psychometric 9 
properties than the subscales (Allen, Byrne, Lampard, Watson & Fursland, 2011). The EDE-10 
Q was also used to provide frequencies of objective binge-eating, vomiting and laxative 11 
abuse (over the previous 28 days). 12 
 Patient Health Questionnaire (PHQ-9; Kroenke, Spitzer & Williams, 2001). The 13 
PHQ-9 is a nine-item self-report questionnaire, which measures symptoms of depression 14 
over a two-week period.  15 
Data analysis 16 
 Ten patients did not complete therapy, and two negotiated leaving therapy early due 17 
to reluctance to engage in change (loss to therapy rate = 25.5%). A further three patients 18 
completed the treatment but did not provide final outcome data (loss to research rate = 19 
32%). Prediction of attrition was tested using chi-squared and independent sample t-tests. 20 
Intention to treat analyses were used to determine the outcome of treatment. Multiple 21 
imputation (SPSS v.24 ± Fully Conditional Specification method, based on linear regression) 22 
was used to deal with missing data. Paired t-tests were used to determine changes in 23 
V\PSWRPVDQG&RKHQ¶Vd was used as the measure of effect size. Remission was defined 24 
by the patient meeting the following criteria at the end of therapy ± BMI > 18.5, absence of 25 
any binge or purge behaviours over the previous month, and an EDE-Q Global score of < 26 
2.77 (one SD above the mean for a UK non-clinical female population).  27 
Partial correlations (controlling for initial EDE-Q score) were used to determine the 28 
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association of temporal factors (age, duration of disorder, number of sessions, duration of 1 
treatment in weeks), initial BMI and initial PHQ-9 scores with final EDE-Q and PHQ-9 2 
scores. Finally, curve fit estimates were used to determine whether there was a relationship 3 
between therapy dose (number of sessions; number of weeks) and the level of change 4 
across therapy (completer sample only). Independent samples t-tests were used to 5 
determine whether those receiving more therapy sessions had different outcomes to those 6 
who received fewer, based on the cut-point suggested by those curve fit estimates. 7 
Results 8 
Sample characteristics 9 
Initial EDE-Q and PHQ-9 scores were available for the 47 patients who started 10 
treatment. Demographic details were available on all of these patients, apart from duration of 11 
treatment for three patients and weight for four patients. All four with missing weights had 12 
diagnoses of bulimia nervosa and were at a normal weight (as confirmed at subsequent 13 
therapy sessions). At the beginning of treatment, the mean BMI of the sample was 22.5 (N = 14 
43; SD = 3.87; range = 17.04-32.94). Their mean age was 27.1 years (N = 47; SD = 6.64; 15 
range = 18-42), and the mean duration of the eating disorder was 9.22 years (N = 44; SD = 16 
6.53; range = 1-23). Thirty-five of these patients completed treatment. End of therapy EDE-Q 17 
and PHQ-9 scores were available for 32 patients.  18 
Predictors of attrition 19 
Twelve patients did not complete therapy. This included both those who stopped 20 
attending sessions without prior discussion, and those who negotiated early termination of 21 
therapy sessions due to being unwilling or unable to work on recovery goals within the 22 
service. Thus, there was an overall drop-out rate of 25.5%. There was no evidence that 23 
completer status was associated with diagnosis (chi-squared = 2.73, df = 6, NS) or with any 24 
temporal characteristic (age, duration of eating disorder, number of treatment sessions, 25 
number of weeks in treatment ± F < 2.4, P > .11 in all cases). Independent sample t-tests 26 
were used to compare those who completed therapy and those who dropped out on BMI, 27 
EDE-Q and PHQ-9 scores, but no comparison approached significance (t < 1.7, P > .12 in all 28 
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cases). Therefore, as with other such studies (e.g., Byrne et al., 2011; Waller et al., 2014), 1 
there was no evidence of pre-treatment characteristics that predicted attrition. 2 
Outcome of treatment for eating disorders  3 
 The mean length of treatment for the patients who completed treatment was 17 4 
attended sessions (SD = 5.84; range = 7-33), delivered over a mean of 25.2 weeks (SD = 5 
10.2; range = 10-51.7). It is noteworthy that there was no significant difference in either the 6 
length of treatment in weeks or in the number of sessions completed by anorexia nervosa or 7 
bulimia nervosa cases (t < 1.4 for each of these two treatment duration variables). 8 
Table 1 VKRZVWKHSDWLHQWV¶%0,s, frequency of bulimic behaviours (objective binges, 9 
vomiting and laxative abuse), EDE-Q and PHQ-9 scores at the beginning and end of 10 
treatment. Their pre- and post-therapy scores were compared using paired t-tests (multiple 11 
imputation used to correct for missing data) (IIHFW VL]HV DUH VKRZQ XVLQJ &RKHQ¶V d 12 
(corrected for paired samples). BMI and frequency of laxative abuse were unchanged across 13 
treatment, but there were significant reductions in eating attitudes, depression and bulimic 14 
behaviours. The effect sizes were small to medium for reduction in binge-eating, medium for 15 
the reductions in eating attitudes and vomiting, and large for the reduction in depression 16 
levels. Mean PHQ-9 and EDE-Q total scores both fell to below the clinical scores that have 17 
been identified as indicating a shift to more healthy ranges.  18 
_________________________ 19 
Insert Table 1 about here 20 
_________________________ 21 
 22 
The pre-treatment EDE-Q Global score of this sample (mean = 3.89) was very similar 23 
to the comparable intention to treat figures IRU%\UQHHWDO¶VDQG7XUQHUHWDO¶V24 
clinical samples (means = 3.96 and 4.17, respectively). The end of treatment score for this 25 
JURXSPHDQ ZDVVOLJKWO\ORZHUWKDQWKRVHRI%\UQH¶VDQG7XUQHU¶VVDPSOHVPHDQ 26 
3.00 and 2.92, respectively), which might reflect the more limited inclusion criteria used in 27 
this clinical setting. 28 
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Remission rate 1 
Eleven patients met the full remission criteria at the end of therapy. This represents 2 
23.4% of the 47 patients who started therapy, and 34.4% of the 32 patients who completed 3 
therapy and provided the necessary data. These results are similar to the remission rates 4 
reported from specialist eating disorders services in effectiveness studies (Turner et al., 5 
2015).  6 
Association of patient characteristics with level of improvement  7 
Table 2 shows the associations (partial correlations, controlling for initial EDE-Q 8 
scores) of pre-treatment characteristics (age, duration of eating disorder, BMI, PHQ-9) and 9 
therapy duration (weeks in treatment; number of sessions attended) with post-treatment 10 
EDE-Q Global and PHQ-9 scores. The analyses involving treatment duration were carried 11 
out for the treatment completers only. None of the associations with initial characteristics 12 
approached significance, indicating that treatment outcome was not moderated by initial 13 
severity. 14 
_________________________ 15 
Insert Table 2 about here 16 
_________________________ 17 
 18 
Association of treatment duration with level of improvement  19 
The duration of treatment (measured either in terms of number of sessions or 20 
number of weeks) was also not associated with the final levels of eating attitudes or 21 
depression (Table 2). Such a lack of associations might be explained by therapy effects 22 
being non-linear. For example, effects of early treatment gains might result in a non-linear 23 
pattern of association, where there was less change to be made later in therapy. Therefore, 24 
curve fit estimates were calculated, to determine whether the best explanation of treatment 25 
outcomes (change in EDE-Q total; change in PHQ-9; change in BMI) was a linear, quadratic 26 
or cubic association with each therapy duration variable (length in weeks; number of 27 
sessions). The curve estimates showed that the length of treatment in weeks was not 28 
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associated with change in EDE-Q total score, regardless of whether one considered the 1 
linear, quadratic or cubic effects (F < 0.6 in all cases). Nor was there any effect of length of 2 
treatment on change in PHQ-9 scores (F < 1.7 in all cases) or BMI (F < 0.45 in all cases). 3 
Similarly, the number of sessions was not associated in any of these ways with change in 4 
EDE-Q total scores (F < 0.5 in all cases), PHQ-9 scores (F < 1.5 in all cases), or BMI (F < 5 
1.0 in all cases). Examination of the curves demonstrated that the optimum length of therapy 6 
was between eight and 12 sessions, with gains by that point but no pattern of further gains 7 
thereafter. 8 
To test this examination of the curves, the degree of change in clinical characteristics 9 
was compared between those patients who received up to 12 sessions (N = 14) and those 10 
who received more (N = 23), using independent sample t-tests (multiple imputations used to 11 
correct for missing data). The improvement in EDE-Q scores was slightly greater among 12 
those patients who had fewer sessions (mean reduction = 1.89, SE = 0.38) than among 13 
those who had more sessions (mean reduction = 1.23, SE = 0.45). BMI change also differed 14 
slightly between those who had fewer sessions (mean increase = 0.48, SE = 0.73) and those 15 
who had more (mean reduction = 0.18, SE = 0.73). Finally, the reduction in PHQ-9 scores 16 
was slightly lower among those patients who had fewer sessions (mean reduction = 5.29, 17 
SE = 1.50) than among those who had more sessions (mean reduction = 6.76, SE = 1.25). 18 
However, in none of these cases did the difference approach significance (t < 1.0; NS in all 19 
cases). These findings support the conclusion that additional sessions did not result in better 20 
outcomes. 21 
Discussion 22 
This study aimed to establish whether CBT could be effective in the treatment of 23 
eating disorders when delivered within a primary care setting, and to determine whether 24 
there is a dose-response effect. The retention rate (c.75%) was strong relative to other 25 
effectiveness studies (e.g., Byrne et al., 2011; Turner et al., 2015). CBT was effective in this 26 
setting, reducing eating disorder symptoms and depression. The level of remission was 27 
similar to that shown in effectiveness studies conducted in specialist eating disorder 28 
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services. There was no dose-response effect within this sample, despite the wide range of 1 
sessions (7-33) and despite the fact that clinicians were able to extend the therapy duration 2 
on a case-by-case basis, if they judged that the patient would benefit from more sessions.  3 
  These findings add to the evidence (e.g., Byrne et al., 2011; Fairburn et al., 2009; 4 
Knott et al., 2015; Turner et al., 2015) that the effects of CBT for adults with eating disorders 5 
are generalizable across settings and service configurations, although this conclusion would 6 
be firmer if there had been a waiting list control group. It is possible that the impact would 7 
have been even greater if mirror exposure work had been used for patients with body 8 
avoidance issues. It is worthy of note that these benefits were achieved despite the mean 9 
GXUDWLRQRIWKHSDWLHQWV¶HDWLQJGLVRUGHUV (9.22 years) being longer than is commonly used in 10 
GHILQLWLRQVRIµVHYHUHDQGHQGXULQJ¶HDWLQJGLVRUGHUVDGGLng to the evidence that the duration 11 
of eating disorders is not related to poor outcomes (e.g., Wildes et al., 2017). The lack of 12 
reliable predictors of attrition is similar to findings in the wider literature (Byrne et al., 2011; 13 
Turner et al., 2015), though it is possible that studies with a larger number of participants will 14 
find such predictors, possibly pointing to heuristics that might be used for treatment matching 15 
purposes. 16 
The findings also confirm the finding from the eating disorders and other disorders 17 
(e.g., Bell et al., 2017; Delgadillo et al., 2014) that adding sessions beyond a basic level 18 
does not automatically enhance therapy outcomes. It is well-established that early change in 19 
CBT for eating disorders is very important for longer-term outcomes (Raykos et al., 2013; 20 
Turner et al. 2015; Waller et al., 2014). If treatment gains are limited after 8-12 sessions, 21 
then the importance of making substantial early gains is even more vital than has been 22 
suggested previously. However, such a conclusion will depend on these findings being 23 
replicated with a wider range of outcome measures, and with a well-validated diagnostic 24 
interview (which was not available for this clinical sample). Constructs that were not 25 
specifically measured in this clinical study (e.g., quality of life; longer-term abstinence and 26 
remission) might be influenced more by longer therapy, and therefore merit consideration in 27 
future. 28 
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There are a number of ways in which this research needs to be extended. For 1 
example, studies of single diagnostic groups of patients would be helpful, as it is possible 2 
that the findings will differ according to the ego syntonicity or dystonicity of the disorder (e.g., 3 
anorexia nervosa patients might need longer to engage with the treatment). It will also be 4 
important to understand whether the pragmatic considerations that were implemented in this 5 
real-life setting (e.g., shortening therapy when it was clear that the patient was not 6 
demonstrating motivation to change or when the patient improved rapidly; lengthening 7 
therapy when further work appeared likely to be useful) mean that the findings partially 8 
reflect clinician decisions rather than patient change per se. Schibbye et al. (2015) suggest 9 
that it is possible to develop algorithms for use in progress monitoring and supervision to 10 
enhance such clinical decisions,WVKRXOGDOVREHQRWHGWKDWWKLVVWXG\¶VJHQHUDOLsability was 11 
limited by the fact that the service was not commissioned to treat patients with binge-eating 12 
disorder. Finally, it will also be important to consider how one could measure therapist 13 
competence and treatment fidelity in such real-life settings, as the lack of such 14 
measurements is a weakness in this and most such studies. Measures of competence and 15 
fidelity that can be applied readily using the resources available in everyday clinical settings 16 
would be an asset for demonstrating the viability of rolling out evidence-based therapies to 17 
real-life clinical practice. 18 
If these findings are replicated and extended, they support treatment of eating 19 
disorders within primary care settings, delivered by individual practitioners working in clinical 20 
teams consisting only of CBT therapists. However, they also raise the important 21 
consideration of how long such therapies should be. If the maximum dose response can be 22 
achieved in a much shorter number of sessions than recommended (e.g., Fairburn, 2008), 23 
then the commonly perceived clinical drawback of shorter therapy (weaker outcomes) might 24 
be invalid, while the potential economic and quality of life benefits of offering fewer sessions 25 
(less time per patient spent on treatment; greater access to treatment for more patients) 26 
could be substantial. There is clearly a strong case for investigating the potential of briefer 27 
versions of CBT and other therapies, given these findings and those of Bell et al. (2017). 28 
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Certainly, the case for longer therapies is weakened by such research, and any clinical case 1 
for extension of treatment should be considered in supervision and monitored in practice 2 
(e.g., Schibbye et al., 2015). Finally, clinicians should be encouraged to use frequent 3 
measures of progress, focusing on weekly changes in behaviors and attitudes (e.g., Tatham, 4 
Turner, Mountford, Tritt, Dyas & Waller, 2015). Detailed monitoring of this sort should be 5 
used to identify and drive early change, to indicate when change is slowing, and to measure 6 
whether any extension of therapy is justified.  7 
 8 
 9 
$XWKRUV¶GHFODUDWLRQ of interest 10 
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Table 1  1 
Outcome of treatment for eating disorders in terms of body mass index, eating pathology 2 
(EDE-Q Global score), bulimic behaviours (per month) and depression (PHQ-9), using 3 
multiple imputations to replace missing data (N = 47). 4 
 5 
 
Start of 
treatment 
End of 
treatment 
Paired t-test 
 Mean (SD) Mean (SD) t P d 
Body mass index 22.5 (3.98) 22.5 (3.70) 0.37 NS   - 
EDE-Q total 3.89 (4.04) 2.33 (3.98) 5.88 .001 0.52 
Objective binges (month) 8.55 (10.6) 4.31 (8.78) 2.21 .03 0.33 
Vomiting (month) 6.47 (9.18) 2.55 (7.88) 3.48 .001 0.56 
Laxatives (month) 0.41 (1.71) 0.47 (1.72) 0.21 NS   - 
PHQ-9 depression 13.5 (5.48) 7.42 (6.38) 7.73 .001 1.22 
 6 
  7 
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Table 2 1 
Partial correlations, testing the association between pre-treatment scores and end of 2 
treatment scores on measures of eating pathology (EDE-Q Global), depression (PHQ-9) and 3 
treatment duration, controlling for initial scores on the EDE-Q. Multiple imputation scores 4 
were used for the correlations with initial scores (N = 47), while completer analysis was used 5 
for associations with duration of treatment (N = 32). No associations were significant. 6 
  7 
 8 
 9 
 10 
 11 
 12 
 
End of treatment scores 
 
Initial scores  
EDE-Q Global PHQ-9 
BMI .172 .185 
Age .156 -.220 
Duration of eating disorder .203 -.081 
PHQ-9 .323 - 
Duration of therapy 
  
Number of sessions -.002 -.302 
Weeks in treatment -.068 -.056 
